<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASherman_Antitrust_Act</id>
	<title>Definition:Sherman Antitrust Act - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASherman_Antitrust_Act"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Sherman_Antitrust_Act&amp;action=history"/>
	<updated>2026-04-30T08:46:51Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Sherman_Antitrust_Act&amp;diff=13867&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Sherman_Antitrust_Act&amp;diff=13867&amp;oldid=prev"/>
		<updated>2026-03-13T13:25:43Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;⚖️ &amp;#039;&amp;#039;&amp;#039;Sherman Antitrust Act&amp;#039;&amp;#039;&amp;#039; is a foundational piece of United States federal legislation, enacted in 1890, that prohibits anticompetitive agreements and monopolistic behavior — and its relationship with the insurance industry has been one of the most distinctive in American regulatory history. Unlike most industries subject to federal antitrust oversight, insurance in the U.S. was largely exempted from the Sherman Act&amp;#039;s reach by the [[Definition:McCarran-Ferguson Act | McCarran-Ferguson Act]] of 1945, which declared that state regulation would be the primary framework governing the &amp;quot;business of insurance&amp;quot; so long as states actively regulated it. This partial exemption has allowed certain collaborative practices among [[Definition:Insurance carrier | insurers]] — such as the pooling of [[Definition:Loss data | loss data]] and the joint development of [[Definition:Advisory rate | advisory rates]] — that would likely face antitrust scrutiny in other sectors.&lt;br /&gt;
&lt;br /&gt;
🔍 The interplay between the Sherman Act and insurance hinges on the McCarran-Ferguson exemption&amp;#039;s boundaries. Conduct that constitutes &amp;quot;boycott, coercion, or intimidation&amp;quot; remains subject to federal antitrust enforcement regardless of state oversight, and courts have periodically tested where those boundaries lie. In practice, [[Definition:Rating bureau | rating bureaus]] and [[Definition:Insurance advisory organization | advisory organizations]] such as the Insurance Services Office (ISO) collect and distribute aggregated statistical data that [[Definition:Underwriter | underwriters]] use to inform pricing — a practice permitted under the exemption. However, if insurers were to collectively agree on final [[Definition:Premium | premium]] rates or refuse to deal with specific parties in concert, the Sherman Act&amp;#039;s prohibitions on price-fixing and group boycotts would apply. Several landmark cases, including the 1944 Supreme Court decision in &amp;#039;&amp;#039;United States v. South-Eastern Underwriters Association&amp;#039;&amp;#039;, established that insurance transactions crossing state lines constitute interstate commerce and therefore fall within the reach of federal law — a ruling that directly precipitated the McCarran-Ferguson response.&lt;br /&gt;
&lt;br /&gt;
📌 Periodic congressional efforts to repeal or narrow the McCarran-Ferguson exemption reflect ongoing debate about whether the insurance industry&amp;#039;s antitrust treatment remains appropriate. The Competitive Health Insurance Reform Act of 2020, for example, removed the exemption for the health insurance sector specifically. For insurers, [[Definition:Reinsurer | reinsurers]], and [[Definition:Insurance broker | brokers]] operating in the U.S. market, the Sherman Act sets the outer boundary of permissible collaboration — particularly around [[Definition:Rate-making | rate-making]], market allocation, and information sharing. While many other jurisdictions enforce competition law against insurers without a comparable exemption (the European Union&amp;#039;s competition framework, for instance, applies directly to insurance undertakings with only narrow block exemptions for certain cooperative arrangements), the U.S. model remains unique in its historical carve-out and the tensions it continues to generate.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:McCarran-Ferguson Act]]&lt;br /&gt;
* [[Definition:Rating bureau]]&lt;br /&gt;
* [[Definition:Antitrust exemption]]&lt;br /&gt;
* [[Definition:Insurance advisory organization]]&lt;br /&gt;
* [[Definition:Rate-making]]&lt;br /&gt;
* [[Definition:Insurance regulation]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>